| Drug Name |
Rizatriptan |
| Drug ID |
BADD_D01957 |
| Description |
Rizatriptan is a triptan drug used for the treatment of migraine headaches. It is a selective 5-hydroxytryptamine1 receptor subtype agonist. |
| Indications and Usage |
For treatment of acute migraine attacks with or without aura. |
| Marketing Status |
approved |
| ATC Code |
N02CC04 |
| DrugBank ID |
DB00953
|
| KEGG ID |
D08485
|
| MeSH ID |
C093622
|
| PubChem ID |
5078
|
| TTD Drug ID |
D0S9MU
|
| NDC Product Code |
33342-088; 71335-1352; 62938-0020; 65977-0067; 33342-087; 63850-7138; 63850-7119 |
| UNII |
51086HBW8G
|
| Synonyms |
rizatriptan | N,N-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1H-indole-3-yl)ethylamine | rizatriptan benzoate | MK 0462 | MK-0462 | MK-462 | MK 462 | L 705,126 | L-705,126 | L-705126 | L 705126 | Maxalt |
